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Abstract
Background—US hospital discharge datasets typically report facility charges (ie, room and 
board), excluding professional fees (ie, attending physicians’ charges).
Objectives—We aimed to estimate professional fee ratios (PFR) by year and clinical diagnosis 
for use in cost analyses based on hospital discharge data.
Subjects—The subjects consisted of a retrospective cohort of Truven Health MarketScan 2004–
2012 inpatient admissions (n = 23,594,605) and treat-and-release emergency department (ED) 
visits (n = 70,771,576).
Measures—PFR per visit was assessed as total payments divided by facility-only payments.
Research Design—Using ordinary least squares regression models controlling for selected 
characteristics (ie, patient age, comorbidities, etc.), we calculated adjusted mean PFR for 
admissions by health insurance type (commercial or Medicaid) per year overall and by Major 
Diagnostic Category (MDC), Diagnostic Related Group, Healthcare Cost and Utilization Project 
Clinical Classification Software, and primary International Classification of Diseases, 9th Edition, 
Clinical Modification (ICD-9-CM) diagnosis, and for ED visits per year overall and by MDC and 
primary ICD-9-CM diagnosis.
Results—Adjusted mean PFR for 2012 admissions, including preceding ED visits, was 1.264 
(95% CI, 1.264, 1.265) for commercially insured admissions (n = 2,614,326) and 1.177 (1.176, 
1.177) for Medicaid admissions (n = 816,503), indicating professional payments increased total 
per-admission payments by an average 26.4% and 17.7%, respectively, above facility-only 
payments. Adjusted mean PFR for 2012 ED visits was 1.286 (1.286, 1.286) for commercially 
insured visits (n = 8,808,734) and 1.440 (1.439, 1.440) for Medicaid visits (n = 2,994,696). 
Supplemental tables report 2004–2012 annual PFR estimates by clinical classifications.
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Conclusions—Adjustments for professional fees are recommended when hospital facility-only 
financial data from US hospital discharge datasets are used to estimate health care costs.
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Hospital discharge data are routinely collected in most US states and used extensively in 
epidemiologic and economic analyses that aim to inform health policy. Discharge datasets 
typically capture information for all patients discharged from acute care hospitals and report 
patients’ demographic characteristics, diagnoses, procedures, payer type, and hospital 
facility charges.1 The Agency for Healthcare Research and Quality provides publicly 
available, aggregated hospital inpatient and emergency department (ED) discharge data and 
national samples through the Healthcare Cost and Utilization Project (HCUP).2
Hospital discharge datasets are commonly used for cost analysis, health services research, 
and population health surveillance.3,4 The major strengths of hospital discharge data include 
public availability, low cost, and population representativeness. However, key information 
on diagnoses and procedures, comorbidities, race/ethnicity, and payer is not standardized 
across hospitals and states and may be underreported.1,5,6
Hospital discharge datasets have 2 other notable limitations for cost analyses. The first is 
that such datasets report hospitals’ billed charges rather than payments (or revenue) 
received.4 Hospital discharge datasets are thus different from medical claims datasets, which 
report payments to hospitals and providers. Cost-to-charge ratios (CCR) from the Centers 
for Medicare and Medicaid Services can be applied to charges reported in discharge datasets 
to estimate hospital costs from reported charges.5,7 CCR may produce a reasonable proxy 
for payments hospitals receive.8 The second disadvantage of hospital discharge datasets is 
that they typically report only facility charges billed by hospitals, excluding physician, or 
professional fees.4,9 Facility charges include, for example, room and board fees, and all 
other payments to hospitals.10 Professional charges reflect services by physicians and other 
skilled health care professionals licensed for independent practice, including many clinicians 
treating patients in hospitals.10
A lack of professional fees is often identified as a limitation of cost analyses based on 
hospital discharge data.11,12 Some cost studies using such data have applied professional fee 
estimates generated from separate data sources.13,14 Limited information suggests facility-
only costs might underestimate the full cost of hospital visits by 20%–25%.14,15 We aimed 
to estimate professional fee ratios (PFR) for inpatient admissions and treat-and-release ED 
(hereafter ED) visits for use in cost analyses based on hospital discharge data.
METHODS
We used medical claims data to estimate PFR for hospital discharge data. We posited that, 
consistent with limited previous estimates, professional fees might contribute an additional 
20%–25% on top of facility fees to total hospital-based service costs. We identified 
admissions (including those originating in the ED) and ED visits among patients with 
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commercial or Medicaid insurance reported in Truven Health MarketScan 2004–2012 
databases. Market-Scan reports paid insurance claims and encounters from a selection of 
large employers, health plans, and government and public organizations, including 
approximately a dozen Medicaid state agencies.16 MarketScan reports clinical diagnoses and 
associated payments to health care providers; charges submitted by providers are not 
reported.17 The study period reflects availability of MarketScan variables that distinguish 
between facility and professional payments,17 as well as a sufficient number of observations 
to estimate annual PFR stratified by selected clinical classifications [ie, Diagnostic Related 
Group (DRG)]. The primary outcome measures were associations between PFR and selected 
patient and service characteristics and estimated PFR per hospital admission or ED visit 
annually by insurance type (ie, commercial and Medicaid) and selected clinical 
classifications. Secondary outcome measures were annual overall adjusted mean PRF for 
admissions and ED visits by insurance type. Cost data are reported as 2012 USD using the 
Price Indexes for Personal Consumption Expenditures by Function from the US Bureau of 
Economic Analysis.18
PFR Definition
PFR was defined as the ratio of total payments to facility-only payments per admission or 
ED visit. On the basis of financial variables available in MarketScan, we calculated PFR per 
admission as total payment divided by the facility-only payment to the hospital.17 We 
calculated PFR per ED visit as the sum of facility and professional payments for ED services 
divided by the facility-only payment. The resulting PFR estimates were designed to be 
multiplied by facility-only cost estimates from hospital discharge datasets to yield a total 
cost of care per visit. For example, if the estimated facility cost of a patient’s admission 
reported in a hospital discharge dataset is $1000 and the corresponding estimated PFR for 
that patient’s clinical diagnosis that year is 1.240, the total estimated direct medical cost of 
the admission could be calculated as $1240.
Clinical and Payment Classifications
MarketScan reports patients’ clinical diagnoses based on administrative codes, including 
Major Diagnostic Category (MDC) (inpatient and ED), DRG (inpatient), and primary and 
other International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-
CM) diagnoses (inpatient and ED). We applied HCUP Clinical Classifications Software 
(HCUP-CCS) to report PFR by single-level HCUP-CCS (inpatient).19 To ensure sufficient 
sample sizes for PFR estimates stratified by year and diagnosis, we assessed 3-digit, rather 
than the more specific 5-digit, ICD-9-CM classifications. We identified ED services among 
admitted patients using recommended criteria for the data source.17 We combined patients’ 
inpatient (and preceding ED, where applicable) and outpatient ED payment records and 
clinical information for services beginning on the same date and attributed the sum of 
payments and all associated clinical data to a single admission or ED visit.17 Where >1 
ICD-9-CM diagnosis was reported as the primary diagnosis for an admission (< 0.1% of 
analyzed admissions), we assigned the first-listed primary diagnosis as the primary 
diagnosis. We identified the primary diagnosis for ED visits based on the diagnosis to which 
facility payments were attributed. ED visits with >1 primary diagnosis associated with 
facility payments (< 0.5% of the sample) were excluded.
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We excluded admissions and ED visits with missing diagnostic information (ie, MDC, 
DRG, or ICD-9-CM primary diagnosis). We excluded admissions and ED visits with 
illogical diagnostic values (ie, E-code as primary ICD-9-CM diagnosis, or >1 DRG or 
MDC). We excluded admissions and ED visits with illogical payments (ie, negative or zero 
total payments or facility payments, or total payments that were less than reported facility 
payments).
We observed some admissions and ED visits with what appeared to be unreasonably low 
hospital facility payments, which created extreme PFR outliers; for example, facility 
payment <$1 for a multiday admission with professional payments of >$1000. The median 
inpatient facility payment per day was $2858 for commercially insured patients and $1570 
for Medicaid patients over the study period. We excluded records with the lowest 1% of 
facility payments per hospitalized day (ie, <$298 for commercially insured patients and <
$105 for Medicaid patients). The median ED treat-and-release facility payment was $532 for 
commercially insured patients and $139 for Medicaid patients. We excluded records with 
the lowest 1% of facility payments for ED visits (ie, <$32 for commercially insured patients 
and <$17 for Medicaid patients).
Patient and Service Characteristics
To estimate adjusted mean PFR we used multivariable regression models to control for 
factors associated with health care utilization and costs, and therefore hypothesized to 
influence professional fees: patient age (continuous variable), sex (dichotomous), race/
ethnicity (categorical), health insurance plan type [ie, health maintenance organization 
(HMO), etc.; categorical], ED services preceding an admission (dichotomous), number of 
comorbidities (ie, hypertension, diabetes, etc.; continuous), surgery (dichotomous), 
treatment of medical complications (dichotomous), length of inpatient stay, discharge status 
(ie, to home, etc.; categorical), and the hospital’s US state or regional location (ie, 
Connecticut or Northeast region, etc.; categorical).20
Age for Medicaid patients was based on patients’ year of birth. Race/ethnicity was available 
only for Medicaid patients. Adult (18 y old and above) comorbidities were defined by 
HCUP Comorbidity Software, Version 3.7,3,21 which identifies coexisting medical 
conditions that are not the primary reason for a hospital admission. This comorbidity 
classification relied on DRG information, which is not applicable to ED visits; therefore, 
only the inpatient PFR models controlled for comorbidities. For admissions among children 
and adolescents (below 18 y old), we also included as comorbidities selected childhood 
chronic conditions (developmental disabilities and congenital defects) defined by ICD-9-CM 
codes (see Table 1 notes).22 In models based on MDC, CCS, and primary ICD-9-CM 
diagnosis, we included a variable for surgery based on the accompanying DRG (which is 
classified as surgical or medical) in the admission models or based on Current Procedural 
Terminology codes indicating surgery (10000–69999) in ED visit models.23 Admission 
models controlled for treatment of medical complications, defined by ICD-9-CM codes (see 
Table 1 notes).20 Hospital location was reported only for commercially insured admissions 
and ED visits; hospital state was reported for admissions but only region was reported for 
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ED visits. Hospital state was included only in aggregate models of commercially insured 
admissions by year; in models of individual clinical classifications by year, smaller sample 
sizes dictated the use of hospital region, instead. Health insurance plan type, length of 
inpatient stay, and discharge status were analyzed as reported in the data source.
Analysis
Using admissions and ED visits as the units of analysis and PFR as the dependent variable, 
we first assessed associations between PFR and patient and service characteristics described 
previously using multivariable regression models. We then estimated adjusted mean PFR—
as well as associated SE and 95% confidence intervals (CI)—calculated as the mean value 
of the model-predicted PFR for each admission or visit using Stata 13 (College Station, TX) 
margins program.24 Among admissions, we estimated adjusted mean PFR first overall, 
stratified by year and insurance type and controlling for DRG, and then we estimated 
separate models for each clinical classification (ie, MDC, DRG, HCUP-CCS, and primary 
ICD-9-CM diagnosis) annually.16,25,26 Among ED visits, we estimated adjusted mean PFR 
first overall, stratified by year and insurance type and controlling for MDC, and then we 
estimated separate models for each clinical classification (ie, MDC and primary ICD 
diagnosis) annually. Adjusted mean PFR estimates (hereafter simply PFR estimates) for 
clinical classifications with <100 observations are not reported. SAS 9.3 (Cary, NC) was 
used for sample selection and Stata 13 was used for modeling.
PFR estimates as reported here were designed to be multiplied by facility-only hospital costs 
to estimate the total direct medical cost of admissions or ED visits based on financial 
information from hospital discharge data. Because of the computing power and time 
required for this selected presentation of results (ie, 1 model for each clinical diagnosis, by 
insurance type, each year—amounting to tens of thousands of models—and reporting 
estimated PFR per diagnosis and year as the mean value of model-predicted PFR for each 
admission or visit), we used ordinary least squares regression models with robust SE. Model 
results and PFR estimates for 2012 are reported in detail below. PFR estimates—as well 
practical use guidance—for admissions and ED visits 2004–2012 annually overall and by 
clinical diagnosis are reported below and in the accompanying Supplementary Digital 
Content (SDC) files (SDC Table 1, Supplemental Digital Content 1, http://
links.lww.com/MLR/B2, SDC Table 2 Supplemental Digital Content 2, http://
links.lww.com/MLR/B3, SDC Table 3, Supplemental Digital Content 3, http://
links.lww.com/MLR/B4, SDC Table 4, Supplemental Digital Content 4, http://
links.lww.com/MLR/B5, and “How to use professional fee ratio estimates with hospital 
discharge data,” Supplemental Digital Content 5, http://links.lww.com/MLR/B6).
RESULTS
Sample selection is reported in Figures 1 and 2. Included in the analysis were 23,594,605 
admissions (16,120,914 commercially insured admissions and 7,473,691 Medicaid 
admissions) and 70,771,576 treat-and-release ED visits (46,296,227 commercially insured 
visits and 24,475,349 Medicaid visits). Descriptive information by year is reported in SDC 
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Table 1, Supplemental Digital Content 1, http://links.lww.com/MLR/B2 and SDC Table 2, 
Supplemental Digital Content 2, http://links.lww.com/MLR/B3.
Among admissions for commercially insured patients, increased patient age was 
significantly associated with slightly lower PFR (ie, <0.1 percentage point lower per year of 
increased age) from 2004 to 2009 but was not significant from 2010 to 2012 (see Table 1 
below for 2012 model results, see SDC Table 1, Supplemental Digital Content 1, http://
links.lww.com/MLR/B2 for model results for all study years). HMO health plans showed a 
significant but varied relationship with PFR compared with Comprehensive health plans (ie, 
plans with no incentive for patients to use particular providers15). Other health plan types 
generally had significantly higher PFR (ie, 1–3 percentage points higher in 2012) compared 
with Comprehensive insurance. ED services preceding an inpatient admission and 
comorbidities were significantly associated with a higher PFR, as was surgery. Treatment of 
medical complications was associated with a significantly lower PFR, as was length of 
hospital stay. Admissions for patients who were transferred to another facility had higher 
PFR compared with patients discharged to home.
Among admissions for Medicaid patients, increased age and female sex were associated 
with slightly decreased PFR over the study period (see Table 1 below for 2012 model 
results, see SDC Table 1, Supplemental Digital Content 1, http://links.lww.com/MLR/B2 for 
model results for all study years). Admissions among patients with black and other non-
Hispanic race/ethnicity had significantly lower PFR compared with white patients, whereas 
admissions among Hispanic patients had a significant but varied relative relationship with 
PFR over the study period. ED visits preceding admissions, length of stay, discharge 
destination, and surgery demonstrated similar relationships to PFR as the commercially 
insurance models. Compared with Comprehensive health plans, HMO plans had 
significantly higher PFR and patients with capitated plans had lower PFR over the study 
period. In the early part of the study period, admissions among patients with comorbidities 
had lower PFR, whereas in later years PFR was significantly higher. Treatment of medical 
complications did not demonstrate a consistent and significant association with PFR.
Among ED visits for both commercially insured and Medicaid patients, increased patient 
age was consistently and significantly associated with lower PFR (see Table 2 below for 
2012 model results, see SDC Table 2, Supplemental Digital Content 2, http://
links.lww.com/MLR/B3 for model results for all study years). Female sex demonstrated a 
significant but varied relationship with PFR among commercially insured ED visits over the 
study period, but was generally associated with a significantly higher PFR among Medicaid 
visits. Patients with non-Comprehensive health plan types—whether commercial or 
Medicaid insurance—demonstrated varied relationships with PFR relative to 
Comprehensive plans. In the earlier years of the study period, regions outside the Northeast 
demonstrated significantly higher PFR among commercially insured ED visits, although 
beginning in 2009 treatment in the West region was consistently and significantly associated 
with lower PFR compared with the Northeast.
Overall estimated PFR for 2012 admissions, including preceding ED visits, was 1.264 (95% 
CI, 1.264, 1.265) for commercially insured admissions (n = 2,614,326) and 1.177 (1.176, 
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1.177) for Medicaid admissions (n = 816,503), indicating professional payments increased 
total per-admission payments by an average 26.4% and 17.7%, respectively, above facility-
only payments (Table 3). Overall estimated mean PFR for 2012 treat-and-release ED visits 
was 1.286 (1.286, 1.286) for commercially insured visits (n = 8,808,734) and 1.440 (1.439, 
1.440) for Medicaid visits (n = 2,994,696). Controlling for selected patient and health 
service characteristics as well as DRG, the overall estimated PFR per year for commercially 
insured admissions declined 6% over the study period [from 1.342 (1.341, 1.343) in 2004 to 
1.264 (1.264, 1.265) in 2012, significant based on nonoverlapping CIs] (Table 3). The 
overall estimated PFR for Medicaid admissions declined 3% (Table 3). Overall estimated 
PFR for ED visits also declined significantly for both commercially insured and Medicaid 
visits (13% and 3% declines, respectively) from 2004 to 2012 (Table 3).
PFR estimates for the top 100 commercially insured inpatient admissions in the data source 
by DRG in 2012 based on number of admissions are reported in Table 4. PFR estimates by 
all years and clinical classifications are reported in SDC Table 3, Supplemental Digital 
Content 3, http://links.lww.com/MLR/B4 (admissions) and SDC Table 4, Supplemental 
Digital Content 4, http://links.lww.com/MLR/B5 (ED visits).
DISCUSSION
In this study we quantified the amount by which facility-only financial data reported in 
hospital discharge datasets can underestimate the full cost of medical care patients receive 
during hospital admissions and ED visits by excluding professional fees. This study appears 
to be the first to comprehensively quantify professional fees in relation to facility fees for 
admissions and ED visits by year and clinical diagnosis. Financial information in 
MarketScan facilitated annual, diagnosis-specific PFR estimates, adjusted for multiple 
patient and service factors. Estimates by clinical classification reported in the SDC files 
were designed to be directly and easily applied to hospital discharge datasets for cost 
analysis.
This study had a number of limitations. Investigation into why PFR changed significantly 
over the study period or why differences exist between commercially insured and Medicaid 
PFR are beyond the scope of this study. Differences in the direction and significance of 
control variables’ estimated coefficients in the annual regression models suggest variation in 
PFR based on issues we have not observed for this analysis. Such issues could conceivably 
span clinical trends, changes in patients’ care-seeking behavior, policy changes that 
explicitly or inadvertently incentivized clinicians’ diagnostic coding practices, or 
macroeconomic issues. MarketScan data are not nationally representative and the 
MarketScan Medicaid sample includes a limited number of states. US state and region are 
crude indicators of geographic differences in health care costs; we lacked consistent data to 
further control for geographic variation, such as urban/rural location. The study did not 
include admissions and ED visits covered by Medicare; the highest patient age among 
commercially insured admissions was 64 years. A future study could apply the methods 
described here to estimate PFR using Medicare claims data, which is available through 
separate MarketScan datasets for patients with employer-based supplemental insurance.
Peterson et al. Page 7













Some of the observed PFR per visit included in our analysis dataset were high (eg, as much 
as 137 for 2012 commercially insured admissions, indicating that professional fees were 137 
times facility fees for the admission). That was despite excluding records with the lowest 1% 
of facility payments per inpatient day and facility payments per ED visit, based on the 
assumption that those payments represented transactions between hospitals and insurance 
providers based on random, anomalous, and proprietary factors that we could not track 
through the data source. With this exclusion criteria, the right-skewness of the PFR data 
shrunk substantially, providing a more even distribution at all levels. Observations 
remaining with relatively high PFR were plausible; for example, among admissions with 
PFR > 100 in 2012 all involved surgery with complications to multiple parts of the body (ie, 
specialist clinicians with high professional fees) with relatively limited hospital stays (ie, 
low facility costs).
MDC, DRG, and CCS clinical classifications are designed to be comprehensive descriptions 
of patients’ health care needs during a particular admission or visit—and in the case of 
DRG, may be the basis of insurance companies’ payments—whereas primary ICD-9-CM 
diagnoses provide a more limited clinical and financial explanation. For example, the 
designation of patients’ primary diagnosis on hospital discharge records may be based on 
nonclinical decisions, including insurance reimbursement.21 Researchers should apply PFR 
estimates by ICD-9-CM diagnosis with caution (see SDC file, “How to use professional fee 
ratio estimates with hospital discharge data,” Supplemental Digital Content 5, http://
links.lww.com/MLR/B6). This study controlled for several patient and insurance 
characteristics, including health plan type, which controlled for patients with managed care 
insurance. However, this study could not control for provider characteristics, such as 
physician specialty, and hospital facility characteristics, such as ownership, organization, 
and geographic location, which influence health care costs.8,27–30 Hospitals’ costs vary 
widely by service type; for example, maternity services—a frequent cause for inpatient 
admission—are outliers.31 PFR estimates by individual clinical classifications (reported in 
SDC Table 3, Supplemental Digital Content 3, http://links.lww.com/MLR/B4 and SDC 
Table 4, Supplemental Digital Content 4, http://links.lww.com/MLR/B5) are likely more 
relevant for health services research than overall annual PFR (reported in Table 3).
We selected a presentation of results we anticipated would be most relevant to cost analyses 
using hospital discharge data—that is, predicted PFR stratified by year and multiple clinical 
classifications. This aim limited our modeling options. The PFR distribution has a right tail, 
similar to distributions common among health care expenditure variables. Ordinary least 
squares models using transformed expenditure estimates—for example, log or other 
transformations with variations such as the addition of a smearing retransformation factor—
as dependent variables may produce more precise and robust estimates than direct analysis 
of untransformed expenditure variables.32 However, retransformation to the original scale 
(required to fulfill our aim of reporting adjusted mean PFR for direct application to hospital 
discharge data) would have undermined the potential advantages of such an approach. One 
relic of this modeling approach is that the lower 95% CI of predicted PFR for a few clinical 
diagnoses was less than zero, and should not be regarded as credible. Generalized linear 
models are commonly used to model expenditure data,33 although it was not feasible to use 
such models with our computing resources given the very large sample sizes (ie, 2.6 million 
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admissions among commercially insured patients in 2012), the number of models estimated, 
and the presentation of results selected for direct application of PFR estimates to hospital 
discharge data. This study represents a first attempt at creating comprehensive data source 
for PFR estimates; future studies can improve upon the methods proposed here.
This study estimated PFR per admission and ED visit based on payments that hospitals and 
physicians received for medical services, whereas hospital charges reported in hospital 
discharge data multiplied by CCR provide an estimate of hospitals’ costs to provide 
services. Both approaches yield recognized estimates of medical costs, but this means that 
our PFR estimates are not precisely complementary to facility cost estimates from hospital 
discharge data. This issue might be mitigated by recent research suggesting CCR can be a 
reasonable proxy for price (or payments)-to-charge ratios, which are more directly 
analogous to our PFR estimates.8 Despite what might be modest differences in the nature of 
financial data underlying our PFR estimates versus that underlying hospital discharge data, 
we propose that our approach offers a reasonable option for improving cost estimates from 
hospital discharge data by accounting for professional fees.
Excluding professional fees underestimates health care costs. Despite limitations, the PFR 
estimates generated in this study may offer an opportunity to address the systematic and 
substantial underestimation of health care service costs using facility-only costs reported in 
hospital discharge data. Adjustment for professional fees in some manner is recommended 
when hospital facility-only financial data are used to estimate health care costs.
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Sample selection for inpatient admissions by insurance type, 2004–2012. aAdmissions 
excluded if missing patient age, sex, or length of stay. bClinical diagnosis values included: 
DRG= 1–999; MDC= 0–25; primary 3-digit ICD-9-CM: 001–999 (excluding error values 
such as “028”), as well as valid V-values. cAdmissions excluded if hospital facility payment 
$ ≤ 0, total payment $ ≤ 0, or professional fee ratio <1 (ie, suggesting total payment was less 
than the component hospital facility payment). Admissions with the lowest 1% of hospital 
facility payments per inpatient day (ie, total facility payment for admission divided by 
length of stay) excluded. DRG indicates Diagnostic Related Group; MDC, Major Diagnostic 
Category; ICD-9-CM, International Classification of Diseases, International Classification 
of Diseases, 9th Revision, Clinical Modification.
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Sample selection for treat-and-release emergency department visits by insurance type, 2004–
2012. aVisits excluded if missing patient age or sex. bClinical diagnosis values included: 
MDC = 0–25; primary 3-digit ICD-9-CM: 001–999 (excluding error values such as “028”), 
as well as valid V-values. Primary diagnosis with a facility payment was defined as the 
primary visit diagnosis. Visits with >1 primary diagnosis with an associated facility payment 
were excluded. cVisits excluded if hospital facility payment $ ≤ 0 or professional payment $ 
< 0. Visits with the lowest 1% of hospital facility payments excluded. ED indicates 
emergency department; MDC indicates Major Diagnostic Category; ICD-9, International 
Classification of Diseases, 9th Revision, Clinical Modification.
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TABLE 4
Professional Fee Ratio Estimates by Top 100 DRG, Commercially Insured Inpatient Admissions, 2012
DRG Description n
Rank by
Sample Size PFR (95% CI)
25 CRANIOTOMY & ENDOVASCULAR INTRACRANIAL PROCEDURES W 
MCC
5950 77 1.287 (1.277, 1.298)
64 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION W MCC 6407 73 1.165 (1.160, 1.169)
65 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION W CC 7873 60 1.153 (1.151, 1.156)
69 TRANSIENT ISCHEMIA 6736 71 1.178 (1.174, 1.182)
101 SEIZURES W/O MCC 14,254 30 1.202 (1.198, 1.206)
103 HEADACHES W/O MCC 9212 46 1.147 (1.144, 1.150)
153 OTITIS MEDIA & URI W/O MCC 7714 62 1.125 (1.122, 1.128)
164 MAJOR CHEST PROCEDURES W CC 5523 82 1.273 (1.267, 1.279)
176 PULMONARY EMBOLISM W/O MCC 8916 49 1.115 (1.113, 1.117)
189 PULMONARY EDEMA & RESPIRATORY FAILURE 6316 75 1.116 (1.114, 1.118)
190 CHRONIC OBSTRUCTIVE PULMONARY DISEASE W MCC 7428 66 1.122 (1.120, 1.125)
191 CHRONIC OBSTRUCTIVE PULMONARY DISEASE W CC 5665 79 1.119 (1.117, 1.122)
193 SIMPLE PNEUMONIA & PLEURISY W MCC 8304 56 1.133 (1.130, 1.135)
194 SIMPLE PNEUMONIA & PLEURISY W CC 17,823 22 1.115 (1.113, 1.117)
195 SIMPLE PNEUMONIA & PLEURISY W/O CC/MCC 12,173 35 1.104 (1.102, 1.105)
202 BRONCHITIS & ASTHMA W CC/MCC 15,024 28 1.129 (1.127, 1.132)
203 BRONCHITIS & ASTHMA W/O CC/MCC 16,665 23 1.106 (1.104, 1.108)
234 CORONARY BYPASS W CARDIAC CATH W/O MCC 5632 80 1.212 (1.207, 1.218)
247 PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC 16,016 26 1.113 (1.110, 1.116)
249 PERC CARDIOVASC PROC W NON-DRUG-ELUTING STENT W/O MCC 8359 54 1.127 (1.124, 1.131)
251 PERC CARDIOVASC PROC W/O CORONARY ARTERY STENT W/O MCC 6829 70 1.173 (1.165, 1.181)
282 ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE W/O CC/MCC 4802 97 1.146 (1.141, 1.150)
287 CIRCULATORY DISORDERS EXCEPT AMI, W CARD CATH W/O MCC 18,175 20 1.142 (1.139, 1.145)
292 HEART FAILURE & SHOCK W CC 5983 76 1.137 (1.134, 1.140)
300 PERIPHERAL VASCULAR DISORDERS W CC 4742 98 1.130 (1.127, 1.134)
305 HYPERTENSION W/O MCC 4715 99 1.142 (1.139, 1.146)
309 CARDIAC ARRHYTHMIA & CONDUCTION DISORDERS W CC 7949 59 1.158 (1.154, 1.162)
310 CARDIAC ARRHYTHMIA & CONDUCTION DISORDERS W/O CC/MCC 15,066 27 1.153 (1.150, 1.155)
312 SYNCOPE & COLLAPSE 9035 48 1.166 (1.162, 1.170)
313 CHEST PAIN 18,180 19 1.152 (1.149, 1.154)
329 MAJOR SMALL & LARGE BOWEL PROCEDURES W MCC 8245 57 1.192 (1.188, 1.197)
330 MAJOR SMALL & LARGE BOWEL PROCEDURES W CC 18,355 18 1.228 (1.225, 1.231)
331 MAJOR SMALL & LARGE BOWEL PROCEDURES W/O CC/MCC 7789 61 1.247 (1.242, 1.253)
343 APPENDECTOMY W/O COMPLICATED PRINCIPAL DIAG W/O CC/MCC 18,361 17 1.286 (1.279, 1.293)
372 MAJOR GASTROINTESTINAL DISORDERS & PERITONEAL INFECTIONS 
W CC
4696 100 1.125 (1.122, 1.128)
378 G.I. HEMORRHAGE W CC 8829 50 1.189 (1.186, 1.193)
386 INFLAMMATORY BOWEL DISEASE W CC 5867 78 1.154 (1.151, 1.157)
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DRG Description n
Rank by
Sample Size PFR (95% CI)
389 G.I. OBSTRUCTION W CC 6879 69 1.135 (1.132, 1.138)
390 G.I. OBSTRUCTION W/O CC/MCC 7623 63 1.127 (1.124, 1.130)
391 ESOPHAGITIS, GASTROENT & MISC DIGEST DISORDERS W MCC 9424 43 1.164 (1.161, 1.167)
392 ESOPHAGITIS, GASTROENT & MISC DIGEST DISORDERS W/O MCC 57,167 8 1.146 (1.145, 1.148)
394 OTHER DIGESTIVE SYSTEM DIAGNOSES W CC 7366 67 1.150 (1.146, 1.153)
417 LAPAROSCOPIC CHOLECYSTECTOMY W/O C.D.E. W MCC 4815 96 1.250 (1.243, 1.258)
418 LAPAROSCOPIC CHOLECYSTECTOMY W/O C.D.E. W CC 14,253 31 1.296 (1.289, 1.303)
419 LAPAROSCOPIC CHOLECYSTECTOMY W/O C.D.E. W/O CC/MCC 9342 44 1.265 (1.257, 1.272)
439 DISORDERS OF PANCREAS EXCEPT MALIGNANCY W CC 8397 53 1.137 (1.134, 1.140)
440 DISORDERS OF PANCREAS EXCEPT MALIGNANCY W/O CC/MCC 8155 58 1.129 (1.127, 1.132)
460 SPINAL FUSION EXCEPT CERVICAL W/O MCC 22,662 14 1.311 (1.299, 1.324)
470 MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER 
EXTREMITY W/O MCC
85,579 5 1.196 (1.194, 1.197)
472 CERVICAL SPINAL FUSION W CC 6383 74 1.483 (1.464, 1.502)
473 CERVICAL SPINAL FUSION W/O CC/MCC 13,828 32 1.499 (1.485, 1.513)
490 BACK & NECK PROC EXC SPINAL FUSION W CC/MCC OR DISC DEVICE/
NEUROSTIM
5237 89 1.378 (1.361, 1.395)
491 BACK & NECK PROC EXC SPINAL FUSION W/O CC/MCC 11,567 37 1.442 (1.428, 1.456)
493 LOWER EXTREM & HUMER PROC EXCEPT HIP,FOOT,FEMUR W CC 5334 88 1.220 (1.213, 1.228)
494 LOWER EXTREM & HUMER PROC EXCEPT HIP,FOOT,FEMUR W/O 
CC/MCC
9187 47 1.215 (1.209, 1.220)
552 MEDICAL BACK PROBLEMS W/O MCC 7562 65 1.134 (1.129, 1.138)
581 OTHER SKIN, SUBCUT TISS & BREAST PROC W/O CC/MCC 5393 84 1.525 (1.505, 1.546)
603 CELLULITIS W/O MCC 28,612 12 1.125 (1.124, 1.127)
620 O.R. PROCEDURES FOR OBESITY W CC 4928 92 1.310 (1.301, 1.320)
621 O.R. PROCEDURES FOR OBESITY W/O CC/MCC 21,179 15 1.322 (1.314, 1.329)
627 THYROID, PARATHYROID & THYROGLOSSAL PROCEDURES W/O 
CC/MCC
5046 91 1.341 (1.332, 1.351)
638 DIABETES W CC 9257 45 1.130 (1.128, 1.133)
639 DIABETES W/O CC/MCC 8471 52 1.122 (1.120, 1.124)
641 MISC DISORDERS OF NUTRITION,METABOLISM,FLUIDS/
ELECTROLYTES W/O MCC
16,596 24 1.124 (1.122, 1.126)
669 TRANSURETHRAL PROCEDURES W CC 4895 93 1.234 (1.226, 1.242)
682 RENAL FAILURE W MCC 5590 81 1.147 (1.143, 1.152)
683 RENAL FAILURE W CC 8583 51 1.140 (1.137, 1.142)
690 KIDNEY & URINARY TRACT INFECTIONS W/O MCC 14,377 29 1.121 (1.119, 1.123)
694 URINARY STONES W/O ESW LITHOTRIPSY W/O MCC 8339 55 1.164 (1.160, 1.168)
708 MAJOR MALE PELVIC PROCEDURES W/O CC/MCC 7613 64 1.474 (1.462, 1.485)
742 UTERINE & ADNEXA PROC FOR NON-MALIGNANCY W CC/MCC 12,556 34 1.292 (1.286, 1.297)
743 UTERINE & ADNEXA PROC FOR NON-MALIGNANCY W/O CC/MCC 43,753 10 1.327 (1.324, 1.330)
765 CESAREAN SECTION W CC/MCC 71,241 6 1.465 (1.463, 1.467)
766 CESAREAN SECTION W/O CC/MCC 102,725 3 1.521 (1.520, 1.523)
767 VAGINAL DELIVERY W STERILIZATION &/OR D&C 6588 72 1.598 (1.589, 1.607)
774 VAGINAL DELIVERY W COMPLICATING DIAGNOSES 42,034 11 1.580 (1.576, 1.583)
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DRG Description n
Rank by
Sample Size PFR (95% CI)
775 VAGINAL DELIVERY W/O COMPLICATING DIAGNOSES 271,937 1 1.644 (1.642, 1.645)
776 POSTPARTUM & POST ABORTION DIAGNOSES W/O O.R. PROCEDURE 5388 85 1.136 (1.131, 1.141)
778 THREATENED ABORTION 5519 83 1.099 (1.093, 1.106)
781 OTHER ANTEPARTUM DIAGNOSES W MEDICAL COMPLICATIONS 16,031 25 1.135 (1.132, 1.139)
782 OTHER ANTEPARTUM DIAGNOSES W/O MEDICAL COMPLICATIONS 4852 94 1.280 (1.269, 1.291)
790 EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME, 
NEONATE
11,521 38 1.241 (1.235, 1.246)
791 PREMATURITY W MAJOR PROBLEMS 7324 68 1.223 (1.217, 1.229)
792 PREMATURITY W/O MAJOR PROBLEMS 11,766 36 1.191 (1.187, 1.195)
793 FULL TERM NEONATE W MAJOR PROBLEMS 26,979 13 1.288 (1.283, 1.292)
794 NEONATE W OTHER SIGNIFICANT PROBLEMS 58,504 7 1.236 (1.233, 1.238)
795 NORMAL NEWBORN 155,892 2 1.214 (1.213, 1.215)
809 MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL 
W CC
4835 95 1.090 (1.088, 1.092)
812 RED BLOOD CELL DISORDERS W/O MCC 10,784 41 1.132 (1.130, 1.135)
847 CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS 
W CC
11,128 39 1.066 (1.065, 1.068)
853 INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC 5377 86 1.159 (1.154, 1.165)
864 FEVER 5375 87 1.125 (1.122, 1.129)
871 SEPTICEMIA OR SEVERE SEPSIS W/O MV 96+ HOURS W MCC 18,402 16 1.130 (1.128, 1.132)
872 SEPTICEMIA OR SEVERE SEPSIS W/O MV 96+ HOURS W/O MCC 11,064 40 1.116 (1.114, 1.118)
881 DEPRESSIVE NEUROSES 12,682 33 1.135 (1.133, 1.138)
885 PSYCHOSES 100,491 4 1.129 (1.129, 1.130)
897 ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION 
THERAPY W/O MCC
51,095 9 1.084 (1.083, 1.085)
917 POISONING & TOXIC EFFECTS OF DRUGS W MCC 5178 90 1.135 (1.131, 1.139)
918 POISONING & TOXIC EFFECTS OF DRUGS W/O MCC 9536 42 1.132 (1.129, 1.135)
945 REHABILITATION W CC/MCC 17,930 21 1.115 (1.113, 1.117)
Estimates based on data from Truven Health MarketScan data, 2012, Inpatient Admissions files.
Data are average predicted values from ordinary least squares multivariable linear regression models with robust SEs (StataCorp, 2013), adjusted 
for all selected patient and health service characteristics demonstrated in Table 1.
MDC and DRG descriptions from Centers for Medicare and Medicaid Services.25 Historic descriptions from https://www.cms.gov/Research-
Statistics-Data-and-Systems/Statistics-Trends-and-Reports/MedicareFeeforSvcPartsAB/MEDPAR.html.
Professional fee ratio estimates for other years, clinical classifications, and Medicaid patients reported in SDC Table 3, Supplemental Digital 
Content 3, http://links.lww.com/MLR/B4.
CI indicates confidence interval; DRG, Diagnostic Related Group; MDC, Major Diagnostic Category; PFR, professional fee ratio.
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